Innate pharma to participate in the H.C. Wainwright 28th annual global investment conference

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:

H.C. Wainwright 28^th Annual Global Investment Conference

• Dates: September 14–16, 2026
• Location: New York, United States

Fireside chat:

• Date: September 14, 2026
• Time: 4:30 PM EDT / 10:30 PM CEST
• Webcast: Access the webcast

The link to access the live webcast of the fireside chat will also be available on the Events page of the Investors section of Innate Pharma’s website. A replay will be available following the event.